Dickerson FB, Brown CH, Kreyenbuhl JA, Fang L, Goldberg RW, Wohlheiter K, Dixon LB: Obesity among individuals with serious mental illness. Acta Psychiatr Scand. 2006, 113: 306-313. 10.1111/j.1600-0447.2005.00637.x.
Article
CAS
PubMed
Google Scholar
Lean ME, Pajonk FG: Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes. Diabetes Care. 2003, 26: 1597-1605. 10.2337/diacare.26.5.1597.
Article
CAS
PubMed
Google Scholar
Bushe CJ, Bradley AJ, Doshi S, Karagianis J: Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies. Int J Clin Pract. 2009, 63: 1743-1761. 10.1111/j.1742-1241.2009.02224.x.
Article
CAS
PubMed
Google Scholar
Bell RC, Farmer S, Ries R, Srebnik D: Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics. Psychiatr Serv. 2009, 60: 1686-1689. 10.1176/appi.ps.60.12.1686.
Article
PubMed
Google Scholar
Werneke U, Taylor D, Sanders TA: Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Int J Clin Psychopharmacol. 2002, 17: 145-160. 10.1097/00004850-200207000-00001.
Article
CAS
Google Scholar
Faulkner G, Cohn T, Remington G: Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev. 2007, 24: CD005148-
Google Scholar
Ganguli R: Behavioral therapy for weight loss in patients with schizophrenia. J Clin Psychiatry. 2007, 68: 19-25. 10.4088/JCP.0607e14.
Article
PubMed
Google Scholar
Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA: Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions. J Clin Psychopharmacol. 2008, 28: 132-137. 10.1097/JCP.0b013e318166c4f7.
Article
CAS
PubMed
Google Scholar
Alvarez-Jiménez M, Hetrick SE, González-Blanch C, Gleeson JF, McGorry PD: Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry. 2008, 193: 101-107.
Article
PubMed
Google Scholar
Littrell KH, Hilligoss NM, Kirshner CD, Petty RG, Johnson CG: The effects of an educational intervention on antipsychotic-induced weight gain. J Nurs Scholarsh. 2003, 35: 237-241. 10.1111/j.1547-5069.2003.00237.x.
Article
PubMed
Google Scholar
Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R: Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2005, 66: 205-212. 10.4088/JCP.v66n0208.
Article
PubMed
Google Scholar
Evans S, Newton R, Higgins S: Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust N Z J Psychiatry. 2005, 39: 479-486.
PubMed
Google Scholar
Kwon JS, Choi JS, Bahk WM, Yoon Kim C, Hyung Kim C, Chul Shin Y, Park BJ, Geun Oh C: Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. J Clin Psychiatry. 2006, 67: 547-553. 10.4088/JCP.v67n0405.
Article
PubMed
Google Scholar
Weber M, Wyne K: A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophr Res. 2006, 83: 95-101. 10.1016/j.schres.2006.01.008.
Article
PubMed
Google Scholar
Jean-Baptiste M, Tek C, Liskov E, Chakunta UR, Nicholls S, Hassan AQ, Brownell KD, Wexler BE: A pilot study of a weight management program with food provision in schizophrenia. Schizophr Res. 2007, 96: 198-205. 10.1016/j.schres.2007.05.022.
Article
PubMed
Google Scholar
Khazaal Y, Fresard E, Rabia S, Chatton A, Rothen S, Pomini V, Grasset F, Borgeat F, Zullino D: Cognitive behavioural therapy for weight gain associated with antipsychotic drugs. Schizophr Res. 2007, 91: 169-77. 10.1016/j.schres.2006.12.025.
Article
PubMed
Google Scholar
Skouroliakou M, Giannopoulou I, Kostara C, Hannon JC: Effects of nutritional intervention on body weight and body composition of obese psychiatric patients taking olanzapine. Nutrition. 2009, 25: 729-735. 10.1016/j.nut.2008.12.009.
Article
CAS
PubMed
Google Scholar
Vreeland B, Minsky S, Menza M, Radler DR, Roemheld B: A Program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv. 2003, 54: 1155-1157. 10.1176/appi.ps.54.8.1155.
Article
PubMed
Google Scholar
Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M: Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry. 2004, 65: 471-477. 10.4088/JCP.v65n0404.
Article
PubMed
Google Scholar
Ball MP, Coons VB, Buchanan RW: A program for treating olanzapine-related weight gain. Psychiatr Serv. 2001, 52: 967-969. 10.1176/appi.ps.52.7.967.
Article
CAS
PubMed
Google Scholar
Centorrino F, Wurtman JJ, Duca KA, Fellman VH, Fogarty KV, Berry JM, Guay DM, Romeling M, Kidwell J, Cincotta SL, Baldessarini RJ: Weight loss in overweight patients maintained on atypical antipsychotic agents. Int J Obes. 2006, 30: 1011-1016. 10.1038/sj.ijo.0803222.
Article
CAS
Google Scholar
Lindenmayer JP, Khan A, Wance D, Maccabee N, Kaushik S: Outcome evaluation of a structured educational wellness program in patients with severe mental illness. J Clin Psychiatry. 2009, 70: 1385-1396. 10.4088/JCP.08m04740yel.
Article
PubMed
Google Scholar
Pendlebury J, Bushe CJ, Wildgust HJ, Holt RI: Long-term maintenance of weight loss in patients with severe mental illness through a behavioural treatment programme in the UK. Acta Psychiatr Scand. 2007, 115: 286-294. 10.1111/j.1600-0447.2006.00906.x.
Article
CAS
PubMed
Google Scholar
Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y, Lanctôt G, Saindon J, Vincent A, Gagnon S, Tremblay A: Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust N Z J Psychiatry. 2007, 41: 980-989. 10.1080/00048670701689428.
Article
PubMed
Google Scholar
Han TS, McNeill G, Seidell JC, Lean ME: Predicting intra-abdominal fatness from anthropometric measures: the influence of stature. Int J Obes Relat Metab Disord. 1997, 21: 587-593. 10.1038/sj.ijo.0800446.
Article
CAS
PubMed
Google Scholar
Weyer C, Pratley RE, Sable AD, Bogardus C, Ravussin E, Tataranni PA: Energy expenditure, fat oxidation, and body weight regulation: a study of metabolic adaptation to long-term weight change. J Clin Endocrinol Metab. 2000, 85: 1087-1094. 10.1210/jc.85.3.1087.
Article
CAS
PubMed
Google Scholar
Zhu SK, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB: Waist circumference and obesity associated risk factors among whites in the Third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nut. 2002, 76: 743-749.
CAS
Google Scholar
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III): Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001, 285 (16): 2486-2497.
Google Scholar
Scheen AJ, De Hert MA: Abnormal glucose metabolism in patients treated with antipsychotics. Diabetes Metab. 2007, 33: 169-175. 10.1016/j.diabet.2007.01.003.
Article
CAS
PubMed
Google Scholar
Monteleone P, Martiadis V, Maj M: Management of schizophrenia with obesity, metabolic, and endocrinological disorders. Psychiatr Clin North Am. 2009, 32: 775-794. 10.1016/j.psc.2009.08.003.
Article
PubMed
Google Scholar
DiMatteo M, Lepper H, Croghan T: Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med. 2000, 160: 2101-2107. 10.1001/archinte.160.14.2101.
Article
CAS
PubMed
Google Scholar